Lv1
38 积分 2025-03-05 加入
Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease
22天前
已完结
Evaluation of two human immunodeficiency virus-1 genotyping systems: ViroSeq™ 2.0 and an in-house method
22天前
已完结
Urine as a source of biomarkers and biological knowledge in chronic kidney disease
23天前
已完结
Biomarkers in diabetic nephropathy: A comprehensive review of their role in early detection and disease progression monitoring
23天前
已完结
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial
23天前
已完结
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
23天前
已完结
Aldosterone Synthase Inhibitors: A Revival for Treatment of Renal and Cardiovascular Diseases
23天前
已完结
Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial
23天前
已完结
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial
23天前
已完结
Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes
23天前
已完结
Discussion on the idea of scientific and technological layout based on the clinical advantageous disease of Chinese medicine (gout)
皖公网安备34019202002308
